Compound heterozygous mutations in the SLC4A11 gene associated with congenital hereditary endothelial dystrophy in a Chinese family

被引:3
作者
Liu, Min [1 ,2 ]
Jia-Li Xia [1 ]
Yang, Hong [3 ]
Yu, Ling [1 ,3 ]
机构
[1] Southwest Med Univ, Dept Ophthalmol, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China
[2] Peoples Hosp Wenjiang Chengdu, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China
[3] Army Med Univ, Daping Hosp, Army Med Ctr, Dept Ophthalmol, Chongqing 400042, Shapingba, Peoples R China
关键词
Congenital hereditary endothelial dystrophy (CHED); sequencing; mutation; CHED2;
D O I
10.1080/13816810.2022.2051192
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background In this case report, we have described congenital inherited endothelial dystrophy (CHED) caused by two heterozygous missense mutations in two patients. Methods A Chinese family affected by CHED was recruited to identify potential genetic mutations. The proband developed bilateral corneal opacity after birth, and was diagnosed with CHED based on the clinical manifestations. Her younger sister had the same symptoms. Blood samples were collected from four members of the family, including the two sisters and their parents, and full exon sequencing (WES) was used to identify potential genetic mutations in the proband. To verify the identified mutations, Sanger sequencing was performed on samples from other family members. Results Two heterozygous missense variants were found in SLC4A11, a variant NM_032034.4; c.1237 G > A (p.G413R, rs1286683365) in exon 10 and a variant NM_032034.4, c. 698 G > T (p.R233L) in exon 6, and the latter was reported for the first time in this disease. Bioinformatics tools, such as SIFT and PolyPhen, showed that changes in these two amino acids probably affected protein function. Conclusions This study reported the typical clinical symptoms of CHED caused by two heterozygous missense variants (c.1237 G > A and c. 698 G > T) in the SLC4A11 gene in a Chinese family.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 21 条
[1]   Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation [J].
Alka, Kumari ;
Casey, Joseph R. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (10) :4258-4267
[2]   Corneal dystrophies [J].
Bourges, J. -L. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (06) :E177-E192
[3]   Dental caries: Genetic and protein interactions [J].
Cavallari, Tayla ;
Arima, Leticia Yumi ;
Ferrasa, Adriano ;
Moyses, Samuel Jorge ;
Moyses, Simone Tetu ;
Herai, Roberto Hirochi ;
Werneck, Renata Iani .
ARCHIVES OF ORAL BIOLOGY, 2019, 108
[4]   Spontaneous regression of congenital corneal opacity [J].
Choe, Sooyeon ;
Yoon, Chang Ho ;
Kim, Mee Kum ;
Hyon, Joon Young ;
Yu, Young Suk ;
Oh, Joo Youn .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (02) :359-366
[5]   Congenital Corneal Endothelial Dystrophies Resulting From Novel De Novo Mutations [J].
Cunnusamy, Khrishen ;
Bowman, Charles B. ;
Beebe, Walter ;
Gong, Xin ;
Hogan, R. Nick ;
Mootha, V. Vinod .
CORNEA, 2016, 35 (02) :281-285
[6]   Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping [J].
Hand, CK ;
Harmon, DL ;
Kennedy, SM ;
FitzSimon, JS ;
Collum, LMT ;
Parfrey, NA .
GENOMICS, 1999, 61 (01) :1-4
[7]   Homozygous SLC4A11 mutation in a large Irish CHED2 pedigree [J].
Hand, Collette K. ;
McGuire, Mairide ;
Parfrey, Nollaig A. ;
Murphy, Conor C. .
OPHTHALMIC GENETICS, 2017, 38 (02) :148-151
[8]  
Kodaganur SG, 2013, MOL VIS, V19, P1694
[9]   Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies [J].
Malhotra, Darpan ;
Casey, Joseph R. .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 178, 2020, 178 :41-81
[10]   Enhancement on Primate Corneal Endothelial Cell Survival In Vitro by a ROCK Inhibitor [J].
Okumura, Naoki ;
Ueno, Morio ;
Koizumi, Noriko ;
Sakamoto, Yuji ;
Hirata, Kana ;
Hamuro, Junji ;
Kinoshita, Shigeru .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (08) :3680-3687